Skip to main content
Frontiers in Microbiology logoLink to Frontiers in Microbiology
. 2026 Sep 17;17:1913467. doi: 10.3389/fmicb.2026.1913467

Dietary supplementation with Lactobacillus plantarum and Bacillus velezensis improves growth performance, antioxidant capacity, immunity and intestinal microbiota in growing-finishing pigs

Zijing Zhang 1, Zihe Li 1, Yingmei Zhang 1, Xinyu Wu 1, Xiaojia Wu 1, Xi Chen 2, Liang Peng 3, Qinghua Liu 1,*, Changchuan Ye 1,*
PMCID: PMC13627412  PMID: 42824202

Abstract

Introduction

Compound probiotics have gained increasing recognition for their ability to improve growth performance and animal health in animal production. This study evaluated the effects of dietary supplementation with Lactobacillus plantarum QZF (1011 CFU/d), Bacillus velezensis BD01 (1012 CFU/d) or their combination on growth performance, serum biochemistry, antioxidant capacity, immunity and gut microbiota in growing pigs.

Methods

A total of 160 growing Landrace × Yorkshire gilts were randomly assigned to four treatment groups: CON (basal diet), SPL (basal diet supplemented with L. plantarum fermentation broth), SPB (basal diet supplemented with B. velezensis fermentation broth), and DP (basal diet supplemented with both strains fermentation broth). Each group consisted of 40 pigs (8 replicates of 5 pigs), and the experiment lasted 47 days.

Results

The SPB and DP groups showed significantly higher average daily gain and serum total protein than CON group, attributed to the main effect of B. velezensis (p(B) < 0.01). The SPL, SPB, and DP groups showed significant increases in serum total cholesterol, free fatty acids and urea nitrogen (p(L) < 0.01 for TC and FFA; p(L) < 0.01, p(B) < 0.01, and p(L × B) < 0.01 for BUN). Serum antioxidant enzyme activities (SOD, CAT, and GSH-Px) were significantly affected by both the main effect of L. plantarum and the main effect of B. velezensis, with no significant L × B interaction. In contrast, total antioxidant capacity (T-AOC) was significantly affected only by the main effect of B. velezensis, whereas neither the main effect of L. plantarum or the L × B interaction was significant. For immune parameters, ALB and IgG were increased by B. velezensis (p(B) < 0.05), while IgM and IgA were elevated by L. plantarum (p(L) < 0.05). No interaction was detected for these parameters. Microbiota analysis revealed increased alpha diversity (ACE and Chao1) and altered microbial composition, with B. velezensis increasing Proteobacteria and the compound probiotic enriching Actinobacteriota and Lactobacillales.

Discussion

In conclusion, dietary probiotics, especially the multi strain combination, positively influenced growth performance, immune function, and antioxidant capacity in growing pigs, representing a promising nutritional strategy for swine production.

Keywords: antioxidant, Bacillus velezensis, growing pigs, immunity, intestinal microbiota, Lactobacillus plantarum, probiotics

Introduction

The use of sub-therapeutic doses of antibiotics in animal feed is a common practice in livestock production, which employed to control infectious diseases and enhance growth performance (Cheng et al., 2014). However, the global rise in antibiotic resistance has become a growing concern in the field of animal health (Mevius and Hellebrekers, 2010). Since 2006, the European Union has completely banned the addition of antibiotics to animal feed. In China, a complete ban on antibiotics in animal feed has also been implemented in 2020. The overuse and misuse of antibiotics have exacerbated resistance issues, highlighting the urgent need to develop safe and effective alternatives for sustainable livestock production (Singer et al., 2019; Zamojska et al., 2021).

In pig production, intestinal health is a key determinant of growth efficiency, nutrient utilization, and disease resistance. Various stressors, including dietary transitions, environmental changes, and pathogenic challenges, can disturb intestinal microbial homeostasis, resulting in impaired nutrient absorption, depressed growth performance and increased incidence of intestinal disorders (Rymut et al., 2021; Tang et al., 2022; Gormley et al., 2024). These issues are especially prominent during the growing period, when pigs undergo rapid development and experience intensive metabolic demands. Dietary probiotics have been recognized as an effective nutritional strategy to alleviate these problems and improve intestinal health and overall production performance.

Probiotics are regarded as promising alternatives to antibiotics due to their beneficial effects on host health and pathogen inhibition. Beneficial microorganisms, such as Lactobacillus, Bacillus and Saccharomyces cerevisiae have been widely applied in livestock, especially in swine production (Kenny et al., 2011). As viable microbial supplements, probiotics can modulate gut microbial composition, enhance intestinal barrier function and strengthen host immune defense, thereby reducing the risk of intestinal diseases (Chandrasekaran et al., 2024). Previous studies have demonstrated that probiotics can alleviate intestinal inflammation by suppressing the expression of pro-inflammatory cytokines and inducing specific regulatory responses in the host (Borchers et al., 2009).

Lactobacillus plantarum is a widely used lactic acid bacterium with strong environmental adaptability and high genomic plasticity. It can produce a variety of bacteriocins with potent antimicrobial activity, showing great potential in food preservation and as an adjunct to antibiotics (Seddik et al., 2017). Dietary supplementation with Lactobacillus species effectively improves growth performance, maintains gastrointestinal microbial balance, and reduces pathogen infection. Studies have confirmed that L. plantarum reduces diarrhea rate and improves intestinal health in pigs (Khongkool et al., 2025; Yang et al., 2022). Bacillus velezensis is another promising probiotic in the livestock industry (Brutscher et al., 2024). Research has shown that B. velezensis promotes growth, enhances immune function and metabolic status, and improves intestinal health and microbial composition in livestock and poultry (Yu et al., 2025; Zhu La et al., 2024). Recently, multi-strain probiotic preparations have attracted increasing attention. Compared with single-strain probiotics, compound probiotics often exert synergistic effects and provide more comprehensive benefits, mainly by inhibiting pathogenic colonization and maintaining intestinal microbial balance (Kim et al., 2024; Li et al., 2023).

Collectively, probiotic supplementation effectively improves growth, immunity and intestinal health in pigs, and multi-strain combinations often show superior effects. This study was conducted to evaluate the effects of dietary supplementation with Lactobacillus plantarum QZF, Bacillus velezensis BD01 or combination of them on growth performance and intestinal health in growing pigs. The results will provide a theoretical basis and practical reference for the application of multi-strain probiotics as antibiotic alternatives in the swine feed industry.

Materials and methods

Experimental design and feeding management

A total of 160 piglets were divided into four treatment groups. The piglets were randomly allocated to the four groups without stratification based on initial body weight. Despite the random allocation process, significant differences in initial body weight still existed across treatment groups. For this reason, ANCOVA was used in subsequent analyses, yet this method could only partially mitigate the above confounding effect. All animals were randomly allocated to four experimental groups, namely CON group, SPL group, SPB group and DP group, with 40 pigs in each group. The 40 pigs within each treatment group were housed in 8 separate pens, containing 5 pigs per pen. The basal diet was formulated to meet the nutritional requirements of growing pigs, and its composition is detailed in Table 1.

Table 1.

Ingredient composition and Nutrient composition of the basal diet (air-dried basis).

Item Contents
Ingredient composition (%)
Corn 68.00
Soy bean meal, 43% 23.00
Wheat bran 5.00
Premix1 4.00
Nutrition content 2 (%)
DE (MJ/kg) 13.78
NE (MJ/kg) 10.60
Crude protein (%) 14.27
Ether extract (%) 3.61
Ash (%) 5.27
Acid detergent fiber (%) 7.79
Neutral detergent fiber (%) 17.18
Dry matter (%) 87.96
Calcium (%) 0.88
Phosphorus (%) 0.54

1 Premix provided the following per kilogram of diet: vitamin A, 5500.00 IU; vitamin D, 2200.00 IU; vitamin E, 30.00 IU; vitamin K3, 2.50mg; vitamin B1, 1.50 mg; vitamin B2, 3.00 mg; vitamin B6, 3.00 mg; vitamin B12, 27.60 μg; nicotinic acid, 30.00 mg; pantothenic acid, 13.80 mg; biotin, 44.00mg; folacin, 0.70 mg; choline, 400.00 mg; Mn, 40.00 mg; Fe, 75.00 mg; Zn, 75.00 mg; Cu, 100.00 mg; I, 0.30 mg; Se, 0.30 mg.

2 DE and NE were calculated value. Crude protein (CP), ether extract (EE), crude ash (Ash), acid detergent fiber (ADF), Neutral detergent fiber (NDF), dry matter (DM), calcium (Ca) and phosphorus (P) were measured and recorded. CP was determined by the Kjeldahl method; EE was determined using the Soxhlet extraction method; ADF and NDF were measured using the filter bag technique; DM was determined using the oven-drying method; Ca was determined by the EDTA complexometric titration method; P was measured by spectrophotometry at a wavelength of 400 nm with the molybdenum blue reaction.

As illustrated in Figure 1, two probiotic strains were used in this study: Lactobacillus plantarum QZF (CGMCC No. 31,389) and Bacillus velezensis BD01 (CGMCC No. 37,239). The probiotic powders, which contained commercially formulated inorganic mineral elements, were provided by Huiying Animal Health Co., Ltd. (Xiamen, China) and stored in sealed, moisture-proof bags at 4 °C until use.

Figure 1.

Diagram illustrates an experimental design for four pig groups: control (sterile water), L. plantarum QZF, B. velezensis BD, and combined L. plantarum QZF plus B. velezensis BD, with general feed, specific treatments, and sampling time points labeled.

The schematic diagram of experimental design in this study.

For preparation, 50 L of water, 750 g of brown sugar, and 500 g of probiotic powder were accurately weighed and thoroughly mixed. The mixture was fermented under anaerobic conditions at 30 °C for 24 h. After fermentation, the viable count of L. plantarum in the fermented suspension was approximately 1 × 108 CFU/mL, and the viable count of B. velezensis was approximately 1 × 109 CFU/mL. The fermented suspensions were freshly prepared and supplied to the corresponding experimental groups every morning between 8:00 and 9:00.

In addition to ad libitum drinking water, the CON group received 2 L of sterile water per pig daily as a supplement. The SPL group received 1 L of L. plantarum suspension (1 × 108 CFU/mL) and 1 L of sterile water per pig daily. The SPB group received 1 L of B. velezensis suspension (1 × 109 CFU/mL) and 1 L of sterile water per pig daily. The DP group received 1 L of L. plantarum suspension (1 × 108 CFU/mL) and 1 L of B. velezensis suspension (1 × 109 CFU/mL) per pig daily. All suspensions were provided as drinking water in separate containers to ensure complete consumption. The daily administration volume of 1 L per pig corresponds to a total daily intake of approximately 1 × 1011 CFU for L. plantarum and 1 × 1012 CFU for B. velezensis.

Before the start of the experiment, all pens were thoroughly cleaned and disinfected. Pigs were assigned to their respective groups and individually identified. Routine disease prevention measures were implemented according to standard protocols. Throughout the trial, the pig house was maintained under natural lighting and ventilation. All pigs had ad libitum access to feed and water. Ambient temperature and humidity were maintained within normal ranges, and pens were disinfected once weekly. Immunizations were administered in accordance with the routine management practices. Animals were monitored daily for general health status, behavioral responses, feed intake, constipation, diarrhea and mortality.

Growth performance

On days 0 and 47 of the experiment, all pigs were individually weighed in the morning after a 12-h overnight fast. The pen (n = 8 per treatment group, with 5 pigs per pen) was considered the experimental unit for growth performance analysis. Initial body weight (IBW), final body weight (FBW), and average daily gain (ADG) were calculated for each individual pig, and the pen-mean values were then used for statistical analysis. Fecal consistency was monitored at fixed times each week throughout the experimental period, and the diarrhea rate was calculated for each pen based on the recorded observations, with pen-level data used for subsequent statistical comparison.

Blood sampling and biochemical analysis

On day 47 of the experiment, after a 12-h overnight feed withdrawal, blood samples were collected from the anterior vena cava using serum separator vacuum tubes. In each treatment group, one pig was randomly selected from each of the eight pens, yielding eight serum samples per group. From these eight samples, six were randomly selected for subsequent analyses. The collected blood samples were centrifuged at 4,000 rpm for 10 min at 4 °C. The supernatant serum was transferred into sterile centrifuge tubes and stored at −20 °C prior to the determination of biochemical, antioxidant, and immune parameters. Repeated freeze–thaw cycles were strictly avoided during storage and analysis.

Fecal sampling and microbial analysis

Fresh fecal samples were collected on day 0 and day 47 of the trial after a 12-h overnight feed withdrawal. In each treatment group, one pig was randomly selected from each of the eight pens, yielding eight fecal samples per group. From these eight samples, six were randomly selected for subsequent analyses. All samples were freshly collected from the pen floor immediately after defecation and transferred into sterile 50 mL centrifuge tubes. All tubes were stored at −20 °C until analysis of gut microbial community composition and calprotectin concentrations.

Serum biochemical parameters, antioxidant capacity and immunity

Serum biochemical parameters were determined using an automated biochemical analysis system (Fuzhou Melisa Biotechnology Co., Ltd., Fuzhou, China). Concentrations of glucose, triglycerides, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, total protein, total cholesterol, and albumin were measured using commercial ELISA kits (Hunan Yonghe Sunshine Technology Co., Ltd., Hunan, China) following the manufacturer's instructions. Serum free fatty acids and urea nitrogen were determined using commercial assay kits (Nanjing Jiancheng Bioengineering Institute, Nanjing, China) according to the protocol.

For antioxidant capacity, the activities of superoxide dismutase, catalase, and glutathione peroxidase, as well as malondialdehyde content and total antioxidant capacity, were measured using corresponding commercial assay kits (Shanghai Liquid Mass Testing Technology Co., Ltd., Shanghai, China).

For immune assessment, serum concentrations of immunoglobulin A, immunoglobulin G, and immunoglobulin M were determined using commercial ELISA kits (Shanghai Yimei Biotechnology Co., Ltd., Shanghai, China).

Fecal calprotectin and microbial composition analysis

Fecal calprotectin levels were determined using a commercial ELISA kit (Shanghai Yimei Biotechnology Co., Ltd., Shanghai, China) according to the manufacturer's protocol. Measurements were performed on fecal samples collected at both the start (day 0) and the end (day 47) of the trial, and the change in calprotectin content (end value minus start value) was calculated for each pig.

To evaluate the effects of dietary probiotic supplementation on the intestinal microbiota of growing pigs, 16S rRNA high-throughput sequencing was performed (Shanghai Yapu Biotechnology Co., Ltd., Shanghai, China). Total microbial DNA was extracted from fecal samples collected at the end of the trial using the cetyltrimethylammonium bromide method following the manufacturer's instructions. The V3–V4 region of the bacterial 16S rRNA gene was amplified with universal primers 338F (ACTCCTACGGGAGGCAGCA) and 806R (GGACTACHVGGGTWTCTAAT), with sequencing adapters added to the primer ends. The amplified products were purified, quantified, normalized, and used to construct a sequencing library. After quality inspection, the library was sequenced on the Illumina NovaSeq 6,000 platform.

Raw sequencing reads were quality-filtered using Trimmomatic v0.33. Primer sequences were removed using cutadapt 1.9.1 to obtain clean reads. Denoising, including paired-end merging and chimera removal, was performed with the DADA2 algorithm in QIIME2 2020.6, generating high-quality amplicon sequence variants (ASVs). Taxonomic annotation of ASVs was conducted using the Silva 138 database and a naive Bayes classifier, providing taxonomic information from phylum to species level. A species abundance table was generated using QIIME software, and community structure visualization was performed with R software based on the ASV abundance table.

Statistics analysis

Statistical analyses were performed using IBM SPSS Statistics version 27.0 (IBM Corp., Armonk, NY, USA). Data analysis was performed using two-way analysis of variance (ANOVA) or two-way analysis of covariance (ANCOVA). For growth performance (final body weight and average daily gain), two-way ANCOVA was adopted with the initial body weight set as the covariate. For the other measured indices, two-way ANOVA was used for statistical analysis. The main effects of L. plantarum supplementation (L), B. velezensis supplementation (B) and their interaction (L × B) were first evaluated. Pairwise comparisons among treatment groups were performed using Tukey's multiple comparison test only when a significant interaction was detected. Results are presented as mean ± standard error of the mean (SEM). In this study, statistical significance was set at p < 0.05.

Results

Growth performance

As shown in Table 2, initial body weight differed significantly among groups [p(L) = 0.37, p(B) = 0.13, p(L × B) < 0.01] using two-way ANOVA. In this case, final body weight (FBW) and average daily gain (ADG) were analyzed using two-way analysis of covariance (ANCOVA) with initial body weight as a covariate. Other parameters were analyzed by two-way ANOVA. Dietary supplementation with B. velezensis (B) significantly increased FBW and ADG [p(B) < 0.01], whereas L. plantarum (L) alone had no significant effect on either parameter [p(L) = 0.76 and 0.60, respectively]. A significant L × B interaction was detected only for ADG [p(L × B) = 0.01]. Although the DP group showed a higher ADG than the CON and SPL groups, its mean ADG was slightly lower than that of the SPB group. Supplementation of L. plantarum significantly reduced diarrhea rate [p(L) < 0.01], while B. velezensis had a trend toward reducing diarrhea rate [p(B) = 0.05]. No interaction was observed for diarrhea rate [p(L × B) = 0.38].

Table 2.

Effects of dietary probiotic supplementation on growth performance.

Items CON(L-B-) SPL(L+B-) SPB(L-B+) DP(L+B+) p-value
L B L×B
FBW (kg) 65.41 ± 0.80 67.10 ± 1.17 69.64 ± 1.02 68.61 ± 0.70 0.73 < 0.01 0.16
ADG (g) 853.13 ± 13.42a 889.50 ± 12.02ab 944.10 ± 7.60c 922.88 ± 9.95bc 0.50 < 0.01 0.01
Diarrhea rate (%) 8.40 ± 0.20 7.90 ± 0.14 8.03 ± 0.09 7.76 ± 0.04 < 0.01 0.04 0.38

FBW, final body weight; ADG, average daily gain. For FBW and ADG, the results are presented as the adjusted mean ± SEM. For diarrhea rate, the results are presented as the mean ± SEM. The original mean of initial body weight (IBW) and FBW were shown in Table S1. n = 8. When a significant interaction was observed, different letters indicate significant differences based on Tukey's multiple comparisons test (P < 0.05).

Serum biochemical parameters

As shown in Table 3, no significant L × B interaction was observed for total protein (TP) and albumin (ALB) [p(L × B) = 0.94 and 0.21, respectively]. Dietary supplementation with B. velezensis (B) significantly increased the contents of total protein (TP) and albumin (ALB) [p(B) < 0.01], while single treatment with L. plantarum had no significant effect on TP and ALB [p(L) = 0.32 and 0.21, respectively]. Dietary supplementation with L. plantarum significantly increased total cholesterol (TC) and free fatty acids (FFA) [p(L) < 0.01], while single supplementation with B. velezensis had no significant effect on TC and FFA [p(B) = 0.38 and 0.15, respectively]. Meanwhile, both L. plantarum and B. velezensis significantly increased blood urea nitrogen (BUN) [p(L) < 0.01, p(B) < 0.01], and a significant interaction was observed [p(L × B) < 0.01]. Nevertheless, both Lactobacillus plantarum and Bacillus velezensis exerted significant main effects, and a significant interaction between the two strains was observed for BUN (p < 0.01). The BUN concentration in the DP group was lower than that in both single-strain groups, suggesting a possible antagonistic effect between the two strains in BUN.

Table 3.

Effects of dietary probiotic supplementation on serum biochemical parameters.

Item CON(L-B-) SPL(L+B-) SPB(L-B+) DP(L+B+) p-value
L B L×B
Glu (mmol/L) 3.80 ± 0.19 3.52 ± 0.15 3.87 ± 0.23 3.95 ± 0.19 0.61 0.22 0.37
TG (mmol/L) 0.45 ± 0.06 0.37 ± 0.06 0.46 ± 0.06 0.36 ± 0.09 0.21 0.99 0.89
HDL-C (mmol/L) 0.68 ± 0.04 0.76 ± 0.08 0.83 ± 0.03 0.80 ± 0.03 0.62 0.08 0.29
LDL-C (mmol/L) 0.59 ± 0.03 0.62 ± 0.06 0.62 ± 0.04 0.57 ± 0.03 0.82 0.82 0.36
TP (g/L) 49.95 ± 1.10 51.38 ± 1.97 55.30 ± 1.10 56.98 ± 1.68 0.32 < 0.01 0.94
TC (mmol/L) 2.45 ± 0.15c 4.77 ± 0.15a 3.48 ± 0.12b 3.47 ± 0.17b < 0.01 0.38 < 0.01
FFA (mmol/L) 0.38 ± 0.04c 0.95 ± 0.04a 0.75 ± 0.02b 0.69 ± 0.04b < 0.01 0.15 < 0.01
BUN (mmol/L) 4.03 ± 0.38b 7.71 ± 0.26a 7.22 ± 0.19a 6.71 ± 0.44a < 0.01 < 0.01 < 0.01
ALB (g/L) 30.58 ± 0.78 30.57 ± 1.68 32.72 ± 1.11 35.85 ± 0.99 0.21 < 0.01 0.21

Glu, Glucose; TG, Triglyceride; HDL-C, High-density lipoprotein; LDL-C, Low-density lipoprotein; TP, Total protein; TC, Total cholesterol; FFA, Free Fatty Acids; BUN, Urea nitrogen; ALB, Albumin. The results are presented as the mean ± SEM. n = 6. When a significant interaction was observed, different letters indicate significant differences based on Tukey's multiple comparisons test (p < 0.05).

Serum antioxidant capacity

As shown in Figure 2, no significant L × B interaction was observed for superoxide dismutase (SOD), catalase (CAT), or glutathione peroxidase (GSH-Px) [p(L × B) = 0.79, 0.67, and 0.73, respectively]. Similarly, no interactive effect was detected for total antioxidant capacity (T-AOC) [p(L × B) = 0.94]. Dietary supplementation with B. velezensis significantly increased T-AOC activity [p(B) = 0.02], whereas L. plantarum alone had no significant effect on T-AOC [p(L) = 0.55]. Both L. plantarum and B. velezensis markedly elevated the levels of SOD, CAT, and GSH-Px [p(L) < 0.01 for all three; p(B) < 0.05 for all three].

Figure 2.

Five grouped bar charts display biochemical parameters SOD, CAT, GSH-Px, MDA, and T-AOC for four sample groups with mean values and error bars; p-values are listed beneath each chart for statistical comparison.

Effects of dietary probiotic supplementation on serum antioxidant capacity in growing pigs. SOD, superoxide dismutase; CAT, catalase; GSH-Px, glutathione peroxidase; MDA, malondialdehyde; T-AOC, total antioxidant capacity. The error bar indicates SEM. n = 6. Data were from Supplementary Tables S2, S4.

Immune parameters and fecal calprotectin content

As shown in Figure 3, no significant L × B interaction was observed for IgG or IgM [p(L × B) = 0.43 and 0.48, respectively]. Dietary supplementation with B. velezensis significantly increased immunoglobulin G (IgG) level [p(B) = 0.03], while single supplementation with L. plantarum had no significant effect on IgG [p(L) = 0.11]. Supplementation with L. plantarum significantly elevated immunoglobulin M (IgM) level [p(L) < 0.01], and single supplementation with B. velezensis showed no significant influence on IgM [p(B) = 0.10]. For IgA, L. plantarum significantly increased its level [p(L) = 0.02], while no significant effect of B. velezensis or L × B interaction was observed [p(B) = 0.13, p(L × B) = 0.08].

Figure 3.

Bar graph panels display serum levels of IgA, IgG, and IgM (in grams per liter) across four groups: CONT-(B-), SPL+(B+), SPB+(B+), and DPL+(B+). IgA and IgM levels are significantly higher in experimental groups versus control, while IgG shows a significant increase only for SPB+(B+). Error bars indicate variability. Panel-specific p-values are reported below each graph.

Effects of dietary probiotic supplementation on immune parameters in growing pigs. IgA, immunoglobulin A; IgG, immunoglobulin G; IgM, immunoglobulin M. The error bar indicates SEM. n = 6. Data were from Supplementary Table S3.

As shown in Figure 4, no significant main effects or interaction were observed for the change in fecal calprotectin (p > 0.05).

Figure 4.

Bar chart displaying changes in fecal calprotectin content in micrograms per gram across four groups labeled CONIL(-B-), SPL(L+B-), SPB(L-B+), and DPL(L+B+). All groups show similar mean values around 1700 with minor error bars. P-values for comparisons are all greater than 0.3, indicating no statistically significant differences.

The change of calprotectin content in growing pigs supplemented diets supplemented with probiotic fermentation broth. The error bar indicates SEM. n = 6. Data were from Supplementary Table S4.

Alpha and beta diversity of fecal microbiota

As shown in Figure 5, the rarefaction curves indicated that the sequencing depth was sufficient to capture the species composition and relative abundance of the intestinal microbial community.

Figure 5.

Line graph titled “Group Rarefaction Curves” showing four colored curves representing CON, SPL, SPB, and DP groups. X-axis displays number of reads sampled, y-axis shows OTUs. Error bars illustrate variability.

Rarefaction curves of the fecal microbial communities. n = 6.

As shown in Table 4, no significant L × B interaction was observed for ACE and Chao1 indices [p(L × B) = 0.56 and 0.37, respectively]. Supplementation with either L. plantarum or B. velezensis significantly increased the ACE and Chao1 indices [p(L) < 0.01, p(B) = 0.04 and 0.03, respectively].

Table 4.

Effects of dietary treatments on alpha diversity of fecal microbiota in growing pigs.

Items CON(L-B-) SPL(L+B-) SPB(L-B+) DP(L+B+) p-value
L B L×B
ACE 714.81 ± 56.19 975.66 ± 50.95 868.87 ± 70.38 1,065.30 ± 37.27 < 0.01 0.04 0.56
Shannon 3.81 ± 0.11 4.11 ± 0.05 3.93 ± 0.12 3.88 ± 0.09 0.21 0.57 0.08
Simpson 0.93 ± 0.01 0.95 ± 0.00 0.93 ± 0.01 0.92 ± 0.01 0.57 0.10 0.10
Chao1 711.07 ± 56.78 986.64 ± 50.08 890.01 ± 69.65 1,065.19 ± 37.50 < 0.01 0.03 0.37

The results are presented as the mean ± SEM. n = 6.

As shown in the Venn diagram (Figure 6A), a total of 1,914 OTUs were identified across the four groups, of which 1,580 were shared among all groups. In total, 67 OTUs were unique to individual groups (CON: 24; SPL: 10; SPB: 13; DP: 20). The total number of OTUs was similar across groups, with the DP group having the highest count (1,787) and the SPL group the lowest (1,756), indicating a high degree of overlap in microbial composition among groups. Beta diversity was assessed by non-metric multidimensional scaling (NMDS) based on Bray–Curtis distance (Figure 6B). The NMDS analysis yielded a stress value of 0.1107 (< 0.2), indicating that the ordination was reliable. Although the NMDS plot showed considerable overlap of ellipses among groups, permutational multivariate analysis of variance (PERMANOVA) revealed that dietary treatment significantly affected beta diversity (pseudo-F = 2.13, R2 = 0.242, p = 0.003).

Figure 6.

Panel A shows a four-set Venn diagram comparing overlaps among groups labeled CON, SPL, SPB, and DP, with numbers indicating shared and unique elements. Panel B presents an NMDS scatter plot with colored clusters representing the same four groups, each ellipse showing group dispersion and overlap along NMDS axes.

(A) Venn diagram of OTUs among the four groups. (B) NMDS analysis of fecal microbial communities based on Bray–Curtis distance. Stress 0.1107. Ellipses represent 95% confidence intervals. PERMANOVA: Pseudo-F 2.13, R2 = 0.242, p = 0.003. n = 6.

Fecal metabolic pathway analysis

LEfSe analysis coupled with KEGG pathway functional prediction revealed distinct enrichment patterns among the treatment groups compared with the CON group (Figure 7). The SPL group exhibited significant enrichment in pathways related to fatty acid biosynthesis, ansamycin biosynthesis, branched-chain amino acid (valine, leucine, and isoleucine) biosynthesis, vancomycin group antibiotic biosynthesis, pantothenate and CoA biosynthesis, and one carbon pool by folate. No significantly enriched pathways were identified in the SPB group. In contrast, the DP group showed significant enrichment in 10 pathways, including one carbon pool by folate, homologous recombination, aminoacyl-tRNA biosynthesis, mismatch repair, peptidoglycan biosynthesis, lysine biosynthesis, D-glutamine and D-glutamate metabolism, ribosome, D-alanine metabolism, and the pentose phosphate pathway.

Figure 7.

Heatmap depicting the abundance of various metabolic and biosynthetic pathways across four sample groups, labeled A-CON, B-SPL, C-SPB, and D-DP. Pathways are listed on the right, color intensity ranges from red (high abundance) to blue (low abundance), and hierarchical clustering is shown on the left.

Heatmap of predicted metabolic pathway abundance based on LEfSe and KEGG analysis. Colors indicate relative enrichment levels (red, increased; blue, decreased). n = 6.

Relative abundance at the phylum level

As shown in (Figure 8A), at the phylum level, Firmicutes, Bacteroidota, Actinobacteriota and Spirochaetota were the dominant phyla across all groups. Dietary supplementation with B. velezensis significantly increased the relative abundance of Firmicutes, Actinobacteriota and Proteobacteria [p(B) = 0.03, 0.05 and < 0.01, respectively], and significantly reduced the relative abundance of Bacteroidota [p(B) = 0.02]. Single supplementation with L. plantarum (L) had no significant effect on the abundances of Firmicutes, Actinobacteriota, Proteobacteria and Bacteroidota [p(L) = 0.62, 0.60, 0.06 and 0.77, respectively]. Supplementation with L. plantarum significantly increased the relative abundance of Verrucomicrobiota [p(L) < 0.01], while single supplementation with B. velezensis had no significant effect on the abundance of Verrucomicrobiota [p(B) = 0.58]. L. plantarum significantly decreased the relative abundance of Spirochaetota [p(L) = 0.02], whereas B. velezensis significantly increased the abundance of Spirochaetota [p(B) = 0.04].

Figure 8.

Panel A presents a stacked bar chart showing the relative abundances of six bacterial phyla across four groups, accompanied by a table listing mean abundances and p-values. Panel B displays a similar bar chart for five bacterial orders and a corresponding data table including mean, standard deviation, and p-values for each group.

The relative abundance of OTUs in the fecal microbiota. (A) Richness and diversity of the fecal microbiota at the phylum level; (B) Richness and diversity of the fecal microbiota at the order level. n = 6.

At the order level (Figure 8B), Lactobacillales, Bacteroidales, Oscillospirales, Lachnospirales, and Clostridiales were the dominant orders. No significant interaction was observed for Lactobacillales, Bacteroidales, Oscillospirales and Enterobacterales at the order level [p(L × B) =0.06, 0.48, 0.27 and 0.14, respectively]. Dietary supplementation with B. velezensis significantly increased the relative abundance of Lactobacillales [P(B) = 0.03] and decreased the relative abundance of Bacteroidales [p(B) = 0.02]. Single supplementation with L. plantarum had no significant effect on the abundances of Lactobacillales and Bacteroidales [p(L) = 0.35 and 0.77, respectively]. Supplementation with L. plantarum significantly reduced the relative abundance of Oscillospirales [p(L) = 0.05], while single supplementation with B. velezensis exerted no significant influence on the abundance of Oscillospirales [p(B) = 0.15]. Meanwhile, both L. plantarum and B. velezensis significantly elevated the relative abundance of Enterobacterales [p(L) < 0.01, p(B) < 0.01].

Discussion

Probiotics can enhance immune responses, maintain intestinal health, improve growth performance and reduce pathogen infection (Pereira et al., 2022), thereby exerting positive effects on growth performance (Kang et al., 2021; Mun et al., 2021; Song et al., 2025). Certain probiotic strains improve growth performance and feed conversion rate in pigs, and can even benefit offspring when supplemented to lactating sows (Vasquez et al., 2022; Parada et al., 2024; Chance et al., 2022). Probiotics also alleviate diarrhea severity (He et al., 2020). Multi-strain probiotics, being non-toxic, free of antimicrobial resistance, and residue-free, are recognized as safe feed additives that mitigate weaning stress, preserve intestinal integrity, and promote growth (Li et al., 2025).

In the present study, the SPB and DP groups showed significantly higher ADG and FBW than the CON group (p < 0.01). These findings are consistent with our previous study, which reported that multi-strain probiotics improve gut health and promote growth in growing rabbits (Ye et al., 2025). Two-way ANCOVA revealed a significant L × B interaction for ADG (p = 0.01). Inspection of the group means showed that the ADG in the DP group was slightly lower than that in the SPB group and comparable to that in the SPL group, consistent with the significant L × B interaction detected for ADG. However, this study still has certain limitations. Even though piglets were randomly assigned to different treatments, there were significant differences in initial body weight among groups. Initial body weight was included as a covariate in the analysis of covariance (ANCOVA) model to reduce the influence of unbalanced baseline data on growth performance indicators. However, ANCOVA cannot completely eliminate residual confounding effects. Therefore, caution is needed when interpreting results related to growth performance. Future research may adopt stratified random grouping based on initial body weight to improve the balance and comparability of baseline data across all treatment groups. Additionally, all experimental animals used in this study were gilts. Although this design controls for sex-related variation, it also limits the extrapolation of our findings to male pigs or mixed-sex populations. Future studies should include both sexes to confirm the generalizability of these results. Overall, supplementation with Bacillus velezensis alone or the mixture of the two strains improved growth performance compared with the control group. However, the average daily gain of the compound probiotic group was not higher than that of each single-strain group. Moreover, a significant interaction effect between Lactobacillus plantarum and Bacillus velezensis was detected. These findings suggest that the combined use of the two strains showed a non-additive and antagonistic-like tendency. A possible explanation is that the two strains may compete for similar ecological niches or nutritional resources within the gastrointestinal tract, thereby interfering with each other's efficacy. Future studies should investigate strain-specific compatibility and dose-response relationships to guide the rational design of multi-strain probiotic formulations.

Additionally, the SPL and DP groups significantly reduced diarrhea incidence (p < 0.05), aligning with a previous study that found that probiotics positively influence diarrhea and growth performance (Song et al., 2025). However, the reduction in diarrhea incidence was relatively modest under the experimental conditions of this study. All experimental pigs maintained good overall health, and the baseline incidence of diarrhea was low. In addition, no clinical fecal scoring or pathogen analysis was performed. Therefore, the observed reduction in diarrhea incidence alone is insufficient to serve as direct evidence of improved intestinal health. Future studies are warranted to further investigate the effects of these probiotics on intestinal health using appropriate challenge models (e.g., pathogen-induced diarrhea models) and incorporating comprehensive clinical and microbiological assessments.

Serum biochemical parameters reflect substance metabolism, organ function, and the effects of nutritional strategies. In this study, dietary supplementation with L. plantarum (SPL), B. velezensis (SPB), or their combination (DP) was evaluated for its impact on metabolism. Regarding glucose and lipid metabolism, no significant differences were observed in serum glucose, triglycerides, HDL-C, or LDL-C among groups (p > 0.05), indicating that probiotic supplementation did not affect basal energy metabolism. However, the SPL, SPB, and DP groups showed significantly increased serum total cholesterol and free fatty acids (p < 0.01), suggesting enhanced lipid mobilization and energy supply. In terms of protein metabolism, serum total protein and albumin were significantly higher in the SPB and DP groups (p < 0.05), and serum urea nitrogen was increased in all treatment groups (p < 0.01), indicating improved protein utilization and amino acid metabolism. These findings are consistent with previous reports that multi-strain probiotics increase TP and TC in poultry like ducks (Sun et al., 2022). Two-way ANOVA revealed significant L × B interactions for TC, FFA and BUN (all p < 0.01). For TC and FFA, the interaction was driven by a marked increase in the SPL group, whereas the DP group showed values similar to the SPB group. For BUN, both L and B exerted significant main effects, and the DP group exhibited a moderate increase relative to CON. No significant interaction was observed for TP or ALB, where only the main effect of B. velezensis was significant (p < 0.01). Overall, these results indicate that B. velezensis was the primary driver of improved protein metabolism, while L. plantarum primarily affected lipid metabolism. For BUN, the non-additive pattern contrasts with the additive patterns observed for other parameters, indicating that the metabolic effects of the two strains are pathway-dependent.

Oxidative stress is a critical challenge in modern swine production, leading to reduced growth performance, immune dysfunction, and tissue damage (Barnham et al., 2004). When reactive oxygen species exceed the body's antioxidant defense capacity, damage to biomolecules and cells can occur (Grzegorzewska et al., 2024). Probiotics exert antioxidant effects by producing antioxidant enzymes and enhancing overall antioxidant capacity (Kavyani et al., 2024). SOD and CAT scavenge superoxide anions and hydrogen peroxide, reducing oxidative stress damage (Wu et al., 2025; Choi et al., 2025), while GSH-Px maintains glutathione redox balance by inhibiting lipid peroxidation (Wei, 2024; Brandl et al., 2025). Two-way ANOVA demonstrated significant main effects of both L. plantarum and B. velezensis on serum SOD, CAT and GSH-Px activities, whereas no significant L × B interaction was detected for these parameters. These findings indicate that each probiotic strain independently contributed to enhancing antioxidant enzyme activities, without evidence of synergistic or antagonistic interaction. Although the DP group showed the highest mean values among the treatment groups, the absence of a significant interaction suggests that the combined supplementation did not produce a statistically synergistic effect beyond the additive main effects. Consistent with these findings, previous studies have reported that L. plantarum increases GSH-Px and CAT levels in weaned piglets (Yu et al., 2024), and that multi-strain probiotics significantly elevate SOD and GSH-Px levels (Sun et al., 2022). Overall, both probiotic strains contributed to improving antioxidant status, and the DP group exhibited the highest numerical antioxidant enzyme activities. However, because no significant L × B interaction was detected, these findings support additive rather than synergistic effects of the combined supplementation.

Immunoglobulins are key components of humoral immunity and directly reflect immune defense capacity. IgA, IgM, and IgG respectively maintain mucosal homeostasis (Lisicka et al., 2025), provide first-line humoral defense (Ji et al., 2023) and act as key inflammatory effectors (Seeling et al., 2023). In our experiment, serum IgA levels were significantly increased by L. plantarum supplementation [p(L) = 0.02], with the SPL and DP groups showing higher values than the CON group. Serum IgM levels were significantly higher in the SPL and DP groups [p(L) < 0.01]. For IgG, B. velezensis supplementation significantly increased its level [p(B) = 0.03], and both SPB and DP groups tended to have higher IgG than CON. These results are similar to previous studies showing that dietary supplementation with Bacillus spp. and Lactobacillus reuteri increases serum IgA and IgG levels, thereby enhancing immune function (Kim et al., 2023; Xie et al., 2025). Collectively, dietary supplementation with L. plantarum (IgA and IgM), B. velezensis (IgG) or their combination (covering both humoral arms) promoted immune function in growing pigs.

Calprotectin is a well-established non-invasive biomarker of intestinal inflammation (Carnazzo et al., 2024; Jukic et al., 2021). Probiotic supplementation has been reported to reduce calprotectin levels and alleviate intestinal inflammation in some studies (Fallahi et al., 2013). However, no significant differences were observed in the change of fecal calprotectin among the four groups in this present study (p > 0.05). A plausible explanation is that all pigs remained clinically healthy throughout the trial with a relatively low baseline level of intestinal inflammation, leaving limited room for further reduction. Additionally, the duration of probiotic supplementation may not have been sufficient to induce measurable changes in calprotectin levels.

To further investigate functional changes in the intestinal microbiota, LEfSe analysis coupled with KEGG pathway prediction was performed. Compared with the CON group, the SPL group showed significant enrichment in pathways related to fatty acid biosynthesis, ansamycin biosynthesis, branched-chain amino acid biosynthesis, vancomycin group antibiotic biosynthesis, pantothenate and CoA biosynthesis, and one carbon pool by folate. These enrichment results suggest potential enhancement in lipid metabolism and energy production capacity of the gut microbiota. Nevertheless, these functional profiles are predicted from 16S rRNA gene sequencing instead of direct measurement, so cautious interpretation of these findings is necessary. The DP group showed a marked increase in both the quantity and variety of enriched pathways, which covered folate one-carbon metabolism, aminoacyl-tRNA biosynthesis, peptidoglycan biosynthesis, lysine biosynthesis, D-glutamine and D-glutamate metabolism, D-alanine metabolism, and the pentose phosphate pathway. These pathways participate in fundamental biological processes associated with DNA maintenance, protein synthesis and bacterial anabolism. However, these pathways represent core functions shared by most bacteria, so their enrichment cannot directly serve as evidence for enhanced microbial proliferation or improved host health status. Pathways involved in peptidoglycan biosynthesis and its precursor supply (D-alanine, D-glutamine/glutamate, lysine) collectively support bacterial cell wall synthesis and homeostasis (Monteiro et al., 2018; Barreteau et al., 2008). Enrichment of the pentose phosphate pathway promotes biosynthesis and reducing power generation (Loopmans et al., 2025; TeSlaa et al., 2023). The one carbon pool by folate pathway, enriched in both SPL and DP groups, plays a role in nucleic acid synthesis and cell proliferation, contributing to intestinal microbial metabolic homeostasis. No significantly enriched pathways were detected in the SPB group, suggesting that Bacillus supplementation alone had a relatively mild regulatory effect on gut microbiota function. In conclusion, compared with the intervention of a single strain, multi-strain compound probiotics could induce a broader spectrum of predicted microbial functional pathways. Nevertheless, all the above conclusions are derived from 16S rRNA gene-based functional prediction, and further validation via metagenomic, meta-transcriptomic or metabolomic analyses is still required.

The gut microbiome plays a critical role in host metabolism, immune function, and nutrient absorption (Zhang et al., 2025). Diarrhea, a common intestinal disorder closely associated with microbial imbalance, poses significant challenges to livestock production (Tian et al., 2025). In this study, alpha diversity analysis revealed that the SPL, SPB, and DP groups significantly increased ACE and Chao1 indices, indicating enrichment of low-abundance microbial taxa without altering the evenness of dominant communities. Beta diversity analysis by NMDS showed overlapping ellipses among groups. However, PERMANOVA revealed a significant effect of dietary treatment on community composition (pseudo-F = 2.13, R2 = 0.242, p = 0.003). At the phylum level, the DP group had significantly higher Actinobacteriota abundance. Although the increased abundance of these bacteria may benefit intestinal metabolic activity, current data cannot confirm that changes in intestinal function are directly caused by alterations in such bacterial communities. Proteobacteria abundance was increased in the SPB and DP groups [CON: 0.15%, SPL: 0.24%, SPB: 0.32%, DP: 0.56%; two-way ANOVA indicated a significant main effect of B. velezensis, p(B) < 0.01]. Although these values remained within a generally acceptable range, the potential risk of Proteobacteria expansion should be considered. At the order level, Lactobacillales was enriched in the DP group, suggesting a favorable shift in lactic acid bacteria populations. Enterobacterales abundance was also increased in the SPB and DP groups (CON: 0.12%; SPL: 0.19%; SPB: 0.28%; DP: 0.49%), However, their absolute and relative abundances remained at low levels. Since some species belonging to Enterobacteriales are opportunistic pathogens, further research is required to clarify whether the observed shifts in the composition of this bacterial group carry biological significance. These changes may be influenced by dietary composition, indicating that further optimization of the probiotic formulation is needed. Although the alpha diversity analysis revealed an increase in microbial richness, the specific low-abundance taxa driving this shift have not been identified. As such, the potential functional roles of these microbes in regulating host intestinal health remain speculative. Future studies are needed to verify these effects via high-resolution microbiome profiling and functional assays. It should be noted that correlation analyses between specific microbial taxa and host physiological parameters (e.g., serum biochemical and immune indicators) were not performed in this study. The serum and fecal samples were processed independently during sample handling, making individual-level pairing unavailable. Therefore, the observed microbiota alterations and host responses are presented as parallel findings rather than causal relationships. Future studies with integrated sampling designs that preserve individual-level matching are needed to formally test microbiota–host associations.

In conclusion, dietary supplementation with probiotics, especially multi-strain compound probiotics, improves growth performance, serum biochemical parameters and antioxidant capacity, and modulates gut microbiota-related parameters in growing pigs. Probiotic treatment also remodels the gut microbiota and enhances microbial metabolic pathways. These findings provide theoretical references for developing new health-promoting feed additives in pig production. However, this study still lacks measurements of intestinal morphology, epithelial barrier integrity and histopathological changes. Current data only verify that probiotic supplementation reduces diarrhea incidence and modifies fecal microbial communities, and cannot directly confirm the improvements in intestinal structure and barrier function caused by probiotics. Follow-up research should combine intestinal histology observation, tight junction protein expression detection and intestinal permeability indicators to validate the actual effects of these probiotics on intestinal health.

Funding Statement

The author(s) declared that financial support was received for this work and/or its publication. This study was financially supported by the fund from the National Key Research and Development Program of China (2024YFD1300803 and 2023YFD1600502) and the Natural Science Foundation of Fujian Province (2026J008090).

Footnotes

Edited by: Julio Plaza-Diaz, Children's Hospital of Eastern Ontario (CHEO), Canada

Reviewed by: Zipeng Jiang, Zhejiang University, China

Mercy Cuenca Condoy, Catholic University of Cuenca, Ecuador

Data availability statement

The 16S rRNA sequencing data generated in this study have been deposited in the NCBI Sequence Read Archive (SRA) under BioProject accession number PRJNA1498308. Other datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Ethics statement

The animal studies were approved by Animal Care and Use Committee of Fujian Agriculture and Forestry University (Approval ID: PZCASFAFU25178). The studies were conducted in accordance with the local legislation and institutional requirements. Written informed consent was obtained from the owners for the participation of their animals in this study.

Author contributions

ZZ: Writing – review & editing, Conceptualization, Writing – original draft, Formal analysis, Investigation, Data curation, Resources. ZL: Formal analysis, Writing – review & editing, Writing – original draft, Methodology, Investigation. YZ: Writing – review & editing, Writing – original draft, Investigation, Formal analysis. XinW: Investigation, Writing – review & editing, Formal analysis, Writing – original draft. XiaW: Formal analysis, Writing – review & editing, Writing – original draft, Investigation. XC: Investigation, Formal analysis, Writing – original draft, Writing – review & editing. LP: Writing – original draft, Resources, Writing – review & editing, Investigation. QL: Funding acquisition, Writing – original draft, Supervision, Writing – review & editing, Methodology, Project administration. CY: Project administration, Supervision, Writing – original draft, Methodology, Conceptualization, Funding acquisition, Writing – review & editing.

Conflict of interest

LP was employed by Fujian Huatian Ecological Agriculture and Animal Husbandry co., Ltd.

The remaining author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Generative AI statement

The author(s) declared that Generative AI was used in the creation of this manuscript. Generative AI was used only for language polishing and grammar improvement to enhance the clarity and readability of the text.

Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Supplementary material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fmicb.2026.1913467/full#supplementary-material

Table_1.docx (20.5KB, docx)

References

  1. Barnham K. J., Masters C. L., Bush A. I. (2004). Neurodegenerative diseases and oxidative stress. Nat. Rev. Drug Discov. 3, 205–214. doi: 10.1038/nrd1330 [DOI] [PubMed] [Google Scholar]
  2. Barreteau H., Kovac A., Boniface A., Sova M., Gobec S., Blanot D. (2008). Cytoplasmic steps of peptidoglycan biosynthesis. Fems. Microbiol. Ecol. 32, 168–207. doi: 10.1111/j.1574-6976.2008.00104.x [DOI] [PubMed] [Google Scholar]
  3. Borchers A. T., Selmi C., Meyers F. J., Keen C. L., Gershwin M. E. (2009). Probiotics and immunity. J. Gastroenterol. 44, 26–46. doi: 10.1007/s00535-008-2296-0 [DOI] [PubMed] [Google Scholar]
  4. Brandl N., Seitz R., Sendtner N., Müller M., Gülow K. (2025). Living on the edge: ROS homeostasis in cancer cells and its potential as a therapeutic target. Antioxidants 14:1002. doi: 10.3390/antiox14081002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Brutscher L. M., Gebrechristos S., Garvey S. M., Spears J. L. (2024). Genetic and phenotypic characterization of Bacillus velezensis strain BV379 for human probiotic applications. Microorganisms 12:436. doi: 10.3390/microorganisms12030436 [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Carnazzo V., Redi S., Basile V., Natali P., Gulli F., Equitani F., et al. (2024). Calprotectin: two sides of the same coin. Rheumatology 63, 26–33. doi: 10.1093/rheumatology/kead405 [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Chance J. A., DeRouchey J. M., Amachawadi R. G., Ishengoma V., Nagaraja T. G., Goodband R. D., et al. (2022). Influence of yeast-based pre- and probiotics in lactation and nursery diets on nursery pig performance and antimicrobial resistance of fecal Escherichia coli. J. Anim. Sci. 100:166. doi: 10.1093/jas/skac064.249 [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Chandrasekaran P., Weiskirchen S., Weiskirchen R. (2024). Effects of probiotics on gut microbiota: an overview. Int. J. Mol. Sci. 25:6022. doi: 10.3390/ijms25116022 [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Cheng G., Hao H., Xie S., Wang X., Dai M., Huang L., et al. (2014). Antibiotic alternatives: the substitution of antibiotics in animal husbandry? Front. Microbiol. 5:217. doi: 10.3389/fmicb.2014.00217 [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Choi S. Heo J. H. Kim Y. S. Hong J. Lee S. Oh T. G. et al. (2025). Engineering multi-functional enzyme-mimetic polyphenol-catalase complex for reversing hypoxia and redox homeostasis in vascular and muscular regeneration. ACS Nano. 20, 4891–4909. doi: 10.1021/acsnano.5c16943 [DOI] [PubMed] [Google Scholar]
  11. Fallahi G., Motamed F., Yousefi A., Shafieyoun A., Najafi M., Khodadad A., et al. (2013). The effect of probiotics on fecal calprotectin in patients with cystic fibrosis. Turkish J. Pediatr. 55, 475–478. [PubMed] [Google Scholar]
  12. Gormley A., Garavito-Duarte Y., Kim S. W. (2024). The role of milk oligosaccharides in enhancing intestinal microbiota, intestinal integrity, and immune function in pigs: a comparative review. Biology 13:663. doi: 10.3390/biology13090663 [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Grzegorzewska A. K., Wolak D., Hrabia A. (2024). Effect of tamoxifen treatment on catalase (CAT) and superoxide dismutase (SOD) expression and localization in the hen oviduct. Theriogenology 214, 73–80. doi: 10.1016/j.theriogenology.2023.10.008 [DOI] [PubMed] [Google Scholar]
  14. He Y., Jinno C., Kim K., Wu Z., Tan B., Li X., et al. (2020). Dietary Bacillus spp. enhanced growth and disease resistance of weaned pigs by modulating intestinal microbiota and systemic immunity. J. Anim. Sci. Biotechno. 11:101. doi: 10.1186/s40104-020-00498-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Ji C., Shen H., Su C., Li Y., Chen S., Sharp T. H., et al. (2023). Plasmodium falciparum has evolved multiple mechanisms to hijack human immunoglobulin M. Nat. Commun. 14:2650. doi: 10.1038/s41467-023-38320-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Jukic A., Bakiri L., Wagner E. F., Tilg H., Adolph T. E. (2021). Calprotectin: from biomarker to biological function. Gut 70, 1978–88. doi: 10.1136/gutjnl-2021-324855 [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Kang J., Lee J. J., Cho J. H., Choe J., Kyoung H., Kim S. H., et al. (2021). Effects of dietary inactivated probiotics on growth performance and immune responses of weaned pigs. J. Anim. Sci. Technol. 63, 520–30. doi: 10.5187/jast.2021.e44 [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Kavyani B., Ahmadi S., Nabizadeh E., Abdi M. (2024). Anti-oxidative activity of probiotics; focused on cardiovascular disease, cancer, aging, and obesity. Microb. Pathog. 196:107001. doi: 10.1016/j.micpath.2024.107001 [DOI] [PubMed] [Google Scholar]
  19. Kenny M., Smidt H., Mengheri E., Miller B. (2011). Probiotics - do they have a role in the pig industry? Animal 5, 462–470. doi: 10.1017/S175173111000193X [DOI] [PubMed] [Google Scholar]
  20. Khongkool K., Taweechotipatr M., Payungporn S., Sawaswong V., Lertworapreecha M. (2025). Characterization and evaluation of Lactobacillus plantarum LC5.2 isolated from Thai native pigs for its probiotic potential in gut microbiota modulation and immune enhancement. J. Microbiol. Biotechn. 35:e2503028. doi: 10.4014/jmb.2503.03028 [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Kim D., Min Y., Suminda G. G. D., Hur C. G., Lee S. C., et al. (2023). Bacillus-supplemented diet improves growth performance in Jeju native pigs by modulating myogenesis and adipogenesis. Anim. Biotechnol. 34, 1763–75. doi: 10.1080/10495398.2022.2047996 [DOI] [PubMed] [Google Scholar]
  22. Kim S., Cho J., Keum G. B., Kwak J., Doo H., Choi Y., et al. (2024). Investigation of the impact of multi-strain probiotics containing Saccharomyces cerevisiae on porcine production. J. Anim. Sci. Technol. 66, 876–90. doi: 10.5187/jast.2024.e79 [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Li J., Li H., Zhou Y., Xiang H., Lv M., Ruan B., et al. (2023). Effects of compound probiotics on cecal microbiota and metabolome of swine. Animals 13:1006. doi: 10.3390/ani13061006 [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Li Z., Dai X., Yang F., Zhao W., Xiong Z., Wan W., et al. (2025). Compound probiotics promote the growth of piglets through activating the JAK2/STAT5 signaling pathway. Front. Microbiol. 16:1480077. doi: 10.3389/fmicb.2025.1480077 [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Lisicka W., Earley Z. M., Sifakis J. J., Erickson S. A., Mattingly J. R., Wu-Woods N. J., et al. (2025). Immunoglobulin A controls intestinal virus colonization to preserve immune homeostasis. Cell Host. Microbe. 33, 498–511.e10. doi: 10.1016/j.chom.2025.03.004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Loopmans S., Rohlenova K., van Brussel T., Stockmans I., Moermans K., Peredo N., et al. (2025). The pentose phosphate pathway controls oxidative protein folding and prevents ferroptosis in chondrocytes. Nat. Metab. 7, 182–95. doi: 10.1038/s42255-024-01187-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Mevius D., Hellebrekers L. J. (2010). Antibiotics in animal husbandry: a thorny problem. Ned. Tijdschr. Voor Geneeskd. 154:B629. [PubMed] [Google Scholar]
  28. Monteiro J. M., Pereira A. R., Reichmann N. T., Saraiva B. M., Fernandes P. B., Veiga H., et al. (2018). Peptidoglycan synthesis drives an FtsZ-treadmilling-independent step of cytokinesis. Nature 554, 528–32. doi: 10.1038/nature25506 [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Mun D., Kyoung H., Kong M., Ryu S., Jang K. B., Baek J., et al. (2021). Effects of Bacillus-based probiotics on growth performance, nutrient digestibility, and intestinal health of weaned pigs. J. Anim. Sci. Technol. 63, 1314–27. doi: 10.5187/jast.2021.e109 [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Parada J., Magnoli A., Poloni V., Corti Isgro M., Rosales Cavaglieri L., Luna M. J., et al. (2024). Pediococcus pentosaceus RC007 and Saccharomyces boulardii RC009 as antibiotic alternatives for gut health in post-weaning pigs. J. Appl. Microbiol. 135:282. doi: 10.1093/jambio/lxae282 [DOI] [PubMed] [Google Scholar]
  31. Pereira W. A. Franco S. M. Reis I. L. Mendonça C. M. N Piazentin A. C. et al. (2022). Beneficial effects of probiotics on the pig production cycle: an overview of clinical impacts and performance. Vet. Microbiol. 269:109431. doi: 10.1016/j.vetmic.2022.109431 [DOI] [PubMed] [Google Scholar]
  32. Rymut H. E., Rund L. A., Bolt C. R., Villamil M. B., Southey B. R., Johnson R. W., et al. (2021). The combined effect of weaning stress and immune activation during pig gestation on serum cytokine and analyte concentrations. Animals 11:2274. doi: 10.3390/ani11082274 [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Seddik H. A., Bendali F., Gancel F., Fliss I., Spano G., Drider D. (2017). Lactobacillus plantarum and its probiotic and food potentialities. Probiotics Antimicro. 9, 111–22. doi: 10.1007/s12602-017-9264-z [DOI] [PubMed] [Google Scholar]
  34. Seeling M., Pöhnl M., Kara S., Horstmann N., Riemer C., Wöhner M., et al. (2023). Immunoglobulin G-dependent inhibition of inflammatory bone remodeling requires pattern recognition receptor Dectin-1. Immunity 56, 1046–63.e7. doi: 10.1016/j.immuni.2023.02.019 [DOI] [PubMed] [Google Scholar]
  35. Singer R. S., Porter L. J., Thomson D. U., Gage M., Beaudoin A., Wishnie J. K. (2019). Raising animals without antibiotics: U.S. producer and veterinarian experiences and opinions. Front Vet Sci 6, 452. doi: 10.3389/fvets.2019.00452 [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Song D., Lee J., Yoo Y., Oh H., Chang S., An J., et al. (2025). Effects of probiotics on growth performance, intestinal morphology, intestinal microbiota weaning pig challenged with Escherichia coli and Salmonella enterica. J. Anim. Sci. Technol. 67, 106–36. doi: 10.5187/jast.2023.e119 [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Sun H., Gu T., Li G., Chen L., Tian Y., Xu W., et al. (2022). Effects of compound probiotics on growth performance, serum biochemical and immune indices, antioxidant capacity, and intestinal tissue morphology of Shaoxing Duck. Animals 12:3219. doi: 10.3390/ani12223219 [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Tang X., Xiong K., Fang R., Li M. (2022). Weaning stress and intestinal health of piglets: a review. Front. Immunol. 13:1042778. doi: 10.3389/fimmu.2022.1042778 [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. TeSlaa T., Ralser M., Fan J., Rabinowitz J. D. (2023). The pentose phosphate pathway in health and disease. Nat. Metab. 5, 1275–89. doi: 10.1038/s42255-023-00863-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Tian R., Chong C. J., Bai Y. Y., Chen N., Qiao R. R., Wang K., et al. (2025). The role of gut microbiota in diarrhea and its alleviation through microbiota-targeted interventions. Front. Microbiol. 16:1630823. doi: 10.3389/fmicb.2025.1630823 [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Vasquez R., Oh J. K., Song J. H., Kang D. K. (2022). Gut microbiome-produced metabolites in pigs: a review on their biological functions and the influence of probiotics. J. Anim. Sci. Technol. 64, 671–95. doi: 10.5187/jast.2022.e58 [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Wei C. (2024). The role of glutathione peroxidase 4 in neuronal ferroptosis and its therapeutic potential in ischemic and hemorrhagic stroke. Brain Res. Bull. 217:111065. doi: 10.1016/j.brainresbull.2024.111065 [DOI] [PubMed] [Google Scholar]
  43. Wu J., Liu X., Wen L., Liang C., Sun Z., Liu X., et al. (2025). Peroxidase modification-driven silymarin liposomes for the treatment of liver fibrosis. Nanomed-Nanotechnol. 69:102851. doi: 10.1016/j.nano.2025.102851 [DOI] [PubMed] [Google Scholar]
  44. Xie Q., Yang M., Duanmu Q., Kang M., Wang J., Tan B. E. (2025). Ningxiang pig-derived Lactobacillus reuteri improves the gut health of weaned piglets by regulating intestinal barrier function and cytokine profiles. Sci. Rep-UK 15:3993. doi: 10.1038/s41598-025-87105-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Yang Y., Yan G., Meng X., Wang X., Zhao Z., Zhou S., et al. (2022). Effects of Lactobacillus plantarum and Pediococcus acidilactici co-fermented feed on growth performance and gut microbiota of nursery pigs. Front. Vet. Sci. 9:1076906. doi: 10.3389/fvets.2022.1076906 [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Ye C., Shi M., Ren J., Zhang Y., Zhang Y., Zhang Y., et al. (2025). Effects of compound probiotics on growth performance, immunity, antioxidant capacity and gut microbiota in weaned rabbits. Front. Vet. Sci. 12:1714335. doi: 10.3389/fvets.2025.1714335 [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Yu J., Zuo B., Li Q., Zhao F., Wang J., Huang W., et al. (2024). Dietary supplementation with Lactiplantibacillus plantarum P-8 improves the growth performance and gut microbiota of weaned piglets. Microbiol. Spectr. 12:e0234522. doi: 10.1128/spectrum.02345-22 [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Yu L., Zhang L., Zhang S., Zhao Y., Bi Z., Xu J., et al. (2025). Effects of dietary Bacillus velezensis Y01 supplementation on growth performance, immune function, and cecal microbiota of 1 to 42 days Langya chickens. BMC Microbiol. 25:288. doi: 10.1186/s12866-025-04008-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Zamojska D., Nowak A., Nowak I., Macierzyńska-Piotrowska E. (2021). Probiotics and postbiotics as substitutes of antibiotics in farm animals: a review. Animals 11:3431. doi: 10.3390/ani11123431 [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Zhang Y., Ma Y., Qi Y. (2025). Potential relationship between gut microbiota and animal diarrhea: a systematic review. Front. Microbiol. 16:1637331. doi: 10.3389/fmicb.2025.1637331 [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Zhu La A. T., Wen Q., Xiao Y., Hu D., Liu D., Guo Y., et al. (2024). A new Bacillus velezensis strain CML532 improves chicken growth performance and reduces intestinal Clostridium perfringens colonization. Microorganisms 12:771. doi: 10.3390/microorganisms12040771 [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Table_1.docx (20.5KB, docx)

Data Availability Statement

The 16S rRNA sequencing data generated in this study have been deposited in the NCBI Sequence Read Archive (SRA) under BioProject accession number PRJNA1498308. Other datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.


Articles from Frontiers in Microbiology are provided here courtesy of Frontiers Media SA

RESOURCES